Deutsch English Français

Contact

EP2454284

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2454284

EP2454284 - GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 15.02.2019 Database last updated on 18.11.2024
Former	The patent has been granted Status updated on 09.03.2018
Former	Grant of patent is intended Status updated on 26.10.2017
Former	Examination is in progress Status updated on 08.09.2017
Former	Grant of patent is intended Status updated on 29.05.2017
Former	Examination is in progress Status updated on 30.11.2016
Most recent event Tooltip	10.07.2020	Lapse of the patent in a contracting state New state(s): IS	published on 12.08.2020 [2020/33]
Applicant(s)	For all designated states AIMM Therapeutics B.V. Meibergdreef 45 1105 BA Amsterdam / NL
	For all designated states Genentech, Inc. 1 DNA Way South San Francisco, CA 94080 / US
	[2012/21]
Inventor(s)	01 / BEAUMONT, Tim Hoger Amstellaan 27 1191 GM Ouderkerk a/d Amstel / NL
	02 / KWAKKENBOS, Mark Jeroen Schollenbrugpad 32 1091 ST Amsterdam / NL
	03 / BROWN, Eric J. 1921 Vallejo ST San Francisco, CA 94123 / US
	04 / MORISAKI, John Hiroshi 1200 Clayton Street Unit 9 San Francisco, CA 94114 / US
	05 / HAZENBOS, Wouter L.W. 254 Molimo Drive San Francisco, CA 94127 / US
	06 / MARIATHASAN, Sanjeev 1291 Encina Drive Millbrae, CA 94030 / US
	07 / KAJIHARA, Kimberly 795 33rd Avenue San Francisco, CA 94121 / US
	08 / XIA, Yi 19911 Lindenbrook Ln Cupertino, CA 95014 / US
	[2018/15]
Former [2012/21]	01 / BEAUMONT, Tim Hoger Amstellaan 27 NL-1191 GM Ouderkerk a/d Amstel / NL
	02 / KWAKKENBOS, Mark Jeroen Schollenbrugpad 32 NL-1091 ST Amsterdam / NL
	03 / BROWN, Eric J. 1921 Vallejo ST San Francisco California 94123 / US
	04 / MORISAKI, John Hiroshi 1200 Clayton Street Unit 9 San Francisco California 94114 / US
	05 / HAZENBOS, Wouter L.W. 254 Molimo Drive San Francisco California 94127 / US
	06 / MARIATHASAN, Sanjeev 1291 Encina Drive Millbrae California 94030 / US
	07 / KAJIHARA, Kimberly 795 33rd Avenue San Francisco California 94121 / US
	08 / XIA, Yi 19911 Lindenbrook Ln Cupertino California 95014 / US
Representative(s)	Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB
	[N/P]
Former [2018/15]	Denison, Christopher Marcus, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB
Former [2012/21]	Denison, Christopher Marcus, et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB
Application number, filing date	10734844.3	15.07.2010
	[2018/15]
	WO2010NL50456
Priority number, date	EP20090165558	15.07.2009 Original published format: EP 09165558
	US20090225878P	15.07.2009 Original published format: US 225878 P
	[2012/21]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2011008092
	Date:	20.01.2011
	Language:	EN
	[2011/03]
	Type:	A2 Application without search report
	No.:	EP2454284
	Date:	23.05.2012
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 20.01.2011 takes the place of the publication of the European patent application.
	[2012/21]
	Type:	B1 Patent specification
	No.:	EP2454284
	Date:	11.04.2018
	Language:	EN
	[2018/15]
Search report(s)	International search report - published on:	EP	26.05.2011
Classification	IPC:	C07K16/12, C12N15/13, A61K39/395, A61P31/04	[2012/21]
	CPC:	C07K16/1278 (EP,US); C07K16/12 (KR); G01N33/5091 (US); A61K38/18 (KR); A61K39/00 (KR); A61K39/395 (KR); (+) A61K47/42 (KR); A61K48/00 (KR); A61P31/00 (EP); A61P31/04 (EP); A61P37/04 (EP); A61P37/06 (EP); C07K14/475 (KR); C07K16/1271 (EP,US); C07K16/22 (KR); C07K16/28 (KR); G01N33/6854 (US); G01N33/6893 (US); C07K2317/21 (EP,US); C07K2317/52 (EP,US); C07K2317/56 (EP,US); C07K2317/565 (EP,US); C07K2317/567 (US); G01N2469/10 (US); G01N2800/26 (US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/21]
Extension states	BA	Not yet paid
	ME	Not yet paid
	RS	Not yet paid
Title	German:	SPEZIFISCH AN GRAM-POSITIVE BAKTERIEN BINDENDE VERBINDUNGEN	[2012/21]
	English:	GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS	[2012/21]
	French:	COMPOSÉS DE LIAISON SPÉCIFIQUES DE BACTÉRIES À GRAM POSITIF	[2012/21]
Entry into regional phase	09.02.2012	National basic fee paid
	09.02.2012	Designation fee(s) paid
	09.02.2012	Examination fee paid
Examination procedure	01.07.2011	Request for preliminary examination filed International Preliminary Examining Authority: EP
	09.02.2012	Examination requested [2012/21]
	03.09.2012	Amendment by applicant (claims and/or description)
	18.05.2015	Despatch of a communication from the examining division (Time limit: M06)
	27.11.2015	Reply to a communication from the examining division
	17.05.2016	Despatch of a communication from the examining division (Time limit: M06)
	28.11.2016	Reply to a communication from the examining division
	30.05.2017	Communication of intention to grant the patent
	31.08.2017	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	27.10.2017	Communication of intention to grant the patent
	23.02.2018	Receipt of the translation of the claim(s)
	27.02.2018	Fee for grant paid
	27.02.2018	Fee for publishing/printing paid
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 18.05.2015
Opposition(s)	14.01.2019	No opposition filed within time limit [2019/12]
Fees paid	Renewal fee
	13.07.2012	Renewal fee patent year 03
	08.07.2013	Renewal fee patent year 04
	08.07.2014	Renewal fee patent year 05
	09.07.2015	Renewal fee patent year 06
	11.07.2016	Renewal fee patent year 07
	10.07.2017	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AL	11.04.2018
	CY	11.04.2018
	EE	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	MC	11.04.2018
	MK	11.04.2018
	RO	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	LU	15.07.2018
	MT	15.07.2018
	IS	11.08.2018
	PT	13.08.2018
	[2020/33]
Former [2020/31]	AL	11.04.2018
	CY	11.04.2018
	EE	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	MC	11.04.2018
	MK	11.04.2018
	RO	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	LU	15.07.2018
	MT	15.07.2018
	PT	13.08.2018
Former [2020/08]	AL	11.04.2018
	EE	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	MC	11.04.2018
	RO	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	LU	15.07.2018
	MT	15.07.2018
	PT	13.08.2018
Former [2019/17]	AL	11.04.2018
	EE	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	MC	11.04.2018
	RO	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	LU	15.07.2018
	PT	13.08.2018
Former [2019/15]	AL	11.04.2018
	EE	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	MC	11.04.2018
	RO	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2019/12]	AL	11.04.2018
	EE	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	RO	11.04.2018
	SK	11.04.2018
	SM	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2019/10]	AL	11.04.2018
	EE	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	RO	11.04.2018
	SK	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2019/09]	AL	11.04.2018
	EE	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2019/03]	AL	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
	PT	13.08.2018
Former [2018/52]	AL	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
	GR	12.07.2018
Former [2018/51]	AL	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	LV	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
Former [2018/50]	AL	11.04.2018
	FI	11.04.2018
	HR	11.04.2018
	LT	11.04.2018
	BG	11.07.2018
	NO	11.07.2018
Former [2018/47]	AL	11.04.2018
	FI	11.04.2018
	LT	11.04.2018
	NO	11.07.2018
Former [2018/46]	AL	11.04.2018
	LT	11.04.2018
	NO	11.07.2018
Cited in	International search	[A]WO9623896 (TRUOG PETER [CH], et al);
		[YD]WO2006034488 (GENENTECH INC [US], et al);
		[XY]WO2007141274 (CRUCELL HOLLAND BV [NL], et al);
		[Y]WO2008121616 (MEDIMMUNE INC [US], et al);
	by applicant	US6939543
		WO2006034488
		WO2008141044
		WO2009012256
		WO2009012268
		WO2009052249
		WO2009099728

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p